+

WO2008016385A3 - Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof - Google Patents

Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof Download PDF

Info

Publication number
WO2008016385A3
WO2008016385A3 PCT/US2007/001290 US2007001290W WO2008016385A3 WO 2008016385 A3 WO2008016385 A3 WO 2008016385A3 US 2007001290 W US2007001290 W US 2007001290W WO 2008016385 A3 WO2008016385 A3 WO 2008016385A3
Authority
WO
WIPO (PCT)
Prior art keywords
deacylase
present
methods
polypeptides
invention further
Prior art date
Application number
PCT/US2007/001290
Other languages
French (fr)
Other versions
WO2008016385A2 (en
Inventor
Richard P Darveau
Stephen R Coats
Original Assignee
Univ Washington
Richard P Darveau
Stephen R Coats
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington, Richard P Darveau, Stephen R Coats filed Critical Univ Washington
Publication of WO2008016385A2 publication Critical patent/WO2008016385A2/en
Publication of WO2008016385A3 publication Critical patent/WO2008016385A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

The present invention provides isolated deacylase polypeptides; and deacylase nucleic acids. The present invention further provides methods for identifying inhibitors of a bacterial deacylase and that are candidates for treating a periodontal disease. The present invention further provides antibodies specific for a subject deacylase polypeptide. The present invention further provides diagnostic methods for detecting silent bacterial infections of the gum tissues; diagnostic methods for detecting conditions and disorders that are sequelae of periodontitis; and diagnostic methods for monitoring a patient's response to treatment for a periodontal disease.
PCT/US2007/001290 2006-01-20 2007-01-18 Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof WO2008016385A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76055606P 2006-01-20 2006-01-20
US60/760,556 2006-01-20

Publications (2)

Publication Number Publication Date
WO2008016385A2 WO2008016385A2 (en) 2008-02-07
WO2008016385A3 true WO2008016385A3 (en) 2009-01-08

Family

ID=38997606

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/001290 WO2008016385A2 (en) 2006-01-20 2007-01-18 Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof

Country Status (1)

Country Link
WO (1) WO2008016385A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO652897A0 (en) 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US8129500B2 (en) 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
JP2009544279A (en) 2006-06-27 2009-12-17 オーラル ヘルス オーストラリア ピーティーワイ リミテッド Porphyromonas gingivalis polypeptide useful for prevention of periodontal disease
WO2009006699A1 (en) 2007-07-12 2009-01-15 Oral Health Australia Pty Ltd Biofilm treatment
AU2013203250B2 (en) * 2007-07-12 2014-11-13 Oral Health Australia Pty Ltd Immunology treatment for biofilms
CN102652831A (en) * 2007-07-12 2012-09-05 口腔健康澳洲私人有限公司 Immunology treatment for biofilms
ES2633738T3 (en) 2008-08-29 2017-09-25 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of P. infection gingival
WO2020139784A1 (en) * 2018-12-29 2020-07-02 Weinberg Assa Method to prevent and treat gingival recession by calcium channel blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712102A (en) * 1993-11-10 1998-01-27 Bristol-Myers Squibb Company Method of screening compounds which inhibit P. gingivalis lipopolysaccharide from inhibiting the extravasation of leukocytes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5712102A (en) * 1993-11-10 1998-01-27 Bristol-Myers Squibb Company Method of screening compounds which inhibit P. gingivalis lipopolysaccharide from inhibiting the extravasation of leukocytes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] NELSON ET AL., Database accession no. (NP_906066) *

Also Published As

Publication number Publication date
WO2008016385A2 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
WO2008016385A3 (en) Deacylase polypeptides, deacylase polynucleotides, and methods of use thereof
MY153198A (en) Inhibitors of protein aggregation
WO2005111066A8 (en) Polypeptides from non-typeable haemophilus influenzae
MXPA02011656A (en) Nrg 2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods.
EP1547996A4 (en) DIAGNOSTIC PROBES AND REMEDIES FOR DISEASES HAVING PRION PROTEIN ACCUMULATION AND METHOD OF MARKING
EP1855719A4 (en) NEUTRALIZATION OF MONOCLONAL ANTIBODIES AGAINST CORONAVIRUS ASSOCIATED WITH SEVERE ACUTE RESPIRATORY SYNDROME
AU2003293460A1 (en) Novel application of biosensors for diagnosis and treatment of disease
EP2154157A3 (en) FC region variants
WO2008105797A3 (en) Polynucleotides encoding novel pcsk9 variants
ATE353975T1 (en) DIAGNOSIS OF APOPTOSIS-ASSOCIATED DISEASES BY DETERMINING THE METHYLATION STATE OF APOPTOSIS-ASSOCIATED GENES
WO2008136848A3 (en) Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease
WO2006074450A3 (en) Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
PT2332582E (en) Ace2 activation for treatment of heart, lung and kidney disease and hypertension
TW200734638A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
WO2008103202A3 (en) Hypoxia related genes and proteins for the treatment and diagnosis of pregnancy related complications
MXPA05011085A (en) Compositions and methods relating to stop-1.
NO20070780L (en) Cell Surface Protein.
EP1954826A4 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2007049065A3 (en) Vwfa, collagen and kunitz domain containing protein
WO2006046270A3 (en) Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof
FR2849591B1 (en) DENTAL HYGIENE APPARATUS FOR THE SIMULTANEOUS CLEANING OF THE TEETH OF BOTH MAXILLAR
HK1106001A1 (en) Method of screening for a carnitine transporter agonist or antagonist and its uses
MY147511A (en) Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the mage-a3-marker
WO2007068913A3 (en) SRCR-B Domain Containing Proteins
EP1293570A3 (en) Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07835668

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07835668

Country of ref document: EP

Kind code of ref document: A2

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载